Shandong Xinhua Pharmaceutical Company Limited Class H (HK:0719) has released an update.
Shandong Xinhua Pharmaceutical Company Limited has successfully conducted its Annual General Meeting and H Shareholders’ Class Meeting, where all proposed resolutions except one were passed by poll. Key resolutions included the approval of the company’s annual report, audited financial statements, and the appointment of Grant Thornton as auditors for the upcoming year. Additionally, the company has announced the payment of the 2023 final dividend to its shareholders.
For further insights into HK:0719 stock, check out TipRanks’ Stock Analysis page.
